Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas
Qi Shen1, Shuangwei Zou1, Bo Sheng1, Menghuang Zhao1, Lu-Zhe Sun2, Xueqiong Zhu1 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Department of Cell Systems and Anatomy, University of Texas Health...
Saved in:
Main Authors: | Shen Q (Author), Zou S (Author), Sheng B (Author), Zhao M (Author), Sun LZ (Author), Zhu X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery
by: Carbonell Esteve JL, et al.
Published: (2012) -
Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman
by: Shikha Seth, et al.
Published: (2013) -
Uterine Leiomyomas: An ENIGMA
by: Kempula Geethamala, et al.
Published: (2016) -
Chondroid metaplasia-uterine leiomyoma
by: M S Aishwarya, et al.
Published: (2023) -
Effects of liver depression and psychological stress on human uterine leiomyoma cells by an AR-cAMP-PKA signal transduction pathway
by: Tian Xia, et al.
Published: (2017)